Bone mineral density fall during aromatase inhibitor treatment may predict lower breast cancer recurrence
ConclusionsThe findings suggest an association may exist between lumbar spine BMD change and breast cancer recurrence for patients treated with adjuvant AI. Further research is required to determine whether BMD change can be utilised as a biomarker.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Hilary Martin,
Andrew Redfern Tags: RESEARCH ARTICLE Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Hormones | Men | Menopause | Reclast | Study | Xgeva | Zometa